TRAW - Traws Pharma, Inc.

QQQ $ 612.11 $ 7.61 (1.26 %)

DIA $ 467.12 $ 5.24 (1.13 %)

SPY $ 671.75 $ 6.91 (1.04 %)

TLT $ 91.68 $ 0.35 (0.38 %)

GLD $ 401.36 $ 14.16 (3.64 %)

Previous Close

$ 3.07

Open

$ 2.85

Bid

$ 2.70 x 5

Ask

$ 3.08 x 400

Day's Range

$ 2.80 - $ 3.11

52 Week Range

$ 0.97 - $ 19.44

Volume

182,904

Average Volume

Market Cap

21.69M

Beta (5Y Monthly)

$ 1.10

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2025	06-30-2025	10-Q
2	05-15-2025	03-31-2025	10-Q
3	03-31-2025	12-31-2024	10-K
4	11-14-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-15-2024	03-31-2024	10-Q
7	04-01-2024	12-31-2023	10-K
8	11-14-2023	09-30-2023	10-Q
9	08-14-2023	06-30-2023	10-Q
10	05-15-2023	03-31-2023	10-Q
11	03-30-2023	12-31-2022	10-K
12	11-14-2022	09-30-2022	10-Q
13	08-15-2022	06-30-2022	10-Q
14	05-13-2022	03-31-2022	10-Q
15	03-21-2022	12-31-2021	10-K
16	11-15-2021	09-30-2021	10-Q
17	08-16-2021	06-30-2021	10-Q
18	05-17-2021	03-31-2021	10-Q
19	03-18-2021	12-31-2020	10-K
20	11-16-2020	09-30-2020	10-Q
21	08-12-2020	06-30-2020	10-Q
22	05-15-2020	03-31-2020	10-Q
23	03-27-2020	12-31-2019	10-K
24	11-12-2019	09-30-2019	10-Q
25	08-14-2019	06-30-2019	10-Q
26	05-15-2019	03-31-2019	10-Q
27	04-01-2019	12-31-2018	10-K
28	11-14-2018	09-30-2018	10-Q
29	08-14-2018	06-30-2018	10-Q
30	05-15-2018	03-31-2018	10-Q
31	03-16-2018	12-31-2017	10-K
32	11-09-2017	09-30-2017	10-Q
33	08-14-2017	06-30-2017	10-Q
34	05-15-2017	03-31-2017	10-Q
35	03-29-2017	12-31-2016	10-K
36	11-14-2016	09-30-2016	10-Q
37	08-15-2016	06-30-2016	10-Q
38	05-11-2016	03-31-2016	10-Q
39	03-28-2016	12-31-2015	10-K
40	11-12-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Traws Pharma Doses First Patient With Ratu...
10/14/2025 11:07:23

12 Health Care Stocks Moving In Wednesday'...
09/17/2025 12:12:13

On September 9, Traws Pharma Enters Asset ...
09/12/2025 20:38:51

-SEC Filing

12 Health Care Stocks Moving In Friday's P...
09/05/2025 12:07:53

Traws Pharma Receives HREC Approval To Ini...
08/18/2025 11:08:22

Non-inferiority trial to assess safety and efficacy, including rates of disease rebound and incidence of Long COVID development...

12 Health Care Stocks Moving In Thursday's...
08/14/2025 12:08:55

Traws Pharma Q2 2025 GAAP EPS $(0.11) Up F...
08/14/2025 11:04:09

Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.11) per share. This is a 99.46 percent increase over losses of $(20...

Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

Traws Pharma Seeks FDA Guidance On TXM For...
06/30/2025 10:45:01

Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southe...

why-rh-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket

Why RH Shares Are Trading Higher By Around...
06/13/2025 09:08:07

12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 17:06:51

dow-gains-over-100-points-us-job-openings-increase-in-april

Dow Gains Over 100 Points; US Job Openings...
06/03/2025 16:16:27

us-stocks-mixed-dollar-general-posts-upbeat-earnings

US Stocks Mixed; Dollar General Posts Upbe...
06/03/2025 14:08:20

12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 12:07:39

Traws Pharma Publishes Key Clinical Effica...
06/03/2025 11:03:56

Traws Pharma, Inc. (NASDAQ:TRAW) ("Traws Pharma", "Traws" or "the Company"), a clinical-stage biopharma...

Traws Pharma Receives Written Responses To...
05/27/2025 12:06:57

UPDATE: Traws Pharma Q1 Adj. EPS $(1.58) B...
05/15/2025 12:31:57

Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(8.04) ...

Traws Pharma Werner Cautreels To retire As...
03/28/2025 20:32:41

Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to ...

Traws Pharma To Unveil Next-Gen Oral Antiv...
03/26/2025 11:33:34

Event to highlight the differentiated features of Traws oral small molecule product candidates:Tivoxavir Marboxil, a single dos...

Traws Reports Topline Results From Study E...
03/24/2025 11:20:51

TXM is an investigational oral, small molecule CAP-dependent endonuclease inhibitor designed to be administered as a single-dos...